Physician profile
Lydia Roward
NPI 1578024170
$31,248.25
in general payments reported to CMS, 2019-2025
10 companies · $12K in 2025
The $12K reported for 2025 was more than what 79% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,636 · 2022: $1,223 · 2023: $2,406 · 2024: $13K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Food and Beverage: $4,516 · Travel and Lodging: $2,873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Food and Beverage | $4,515.67 |
| Travel and Lodging | $2,872.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $20,188.64 | 2024-2025 | Evos, Evos Mini, Trigen |
| Stryker Corporation | $9,489.23 | 2021-2025 | Pro, Hoffmann, T2 Alpha |
| Arthrex, INC. | $936.32 | 2025 | |
| Bioventus LLC | $149.31 | 2021 | |
| Mission Medical Distribution, LLC | $128.55 | 2023-2025 | |
| Skeletal Dynamics INC | $116.28 | 2024 | Align, Implate, Geminus |
| Zimmer Biomet Holdings, INC. | $78.48 | 2024 | Persona |
| Peerless Surgical INC. | $59.13 | 2024 | |
| Sanara Medtech INC. | $57.11 | 2022 | |
| Medinc of Texas | $45.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lydia Roward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.